Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects - Wikidata - awgldk - TriplyDB

Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects

Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects

http://www.wikidata.org/entity/Q24613764

about

Psychedelics and mental health: a population study The induction of synaesthesia with chemical agents: a systematic review The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs Superior pattern processing is the essence of the evolved human brain Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model.Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness Lysergic acid diethylamide: a drug of 'use'?Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years The Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of Civilization Recent advances in the neuropsychopharmacology of serotonergic hallucinogens Psychedelics LSD enhances the emotional response to music.Modern Clinical Research on LSD.Looking for the Self: Phenomenology, Neurophysiology and Philosophical Significance of Drug-induced Ego Dissolution.Animal models of serotonergic psychedelics.Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin.Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.Alterations of consciousness and mystical-type experiences after acute LSD in humans.Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects.Harms and benefits associated with psychoactive drugs: findings of an international survey of active drug users.Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes.Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence.Synthesis and structure-activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists.Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction Neuropharmacology of N,N-dimethyltryptamine Clinical applications of hallucinogens: A review.The serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogens.Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction.Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers.High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory (EDI)LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses.Single treatments that have lasting effects: some thoughts on the antidepressant effects of ketamine and botulinum toxin and the anxiolytic effect of psilocybin.Alternative drugs of abuse.The assessment of creativity in creativity/psychopathology research - a systematic review.Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences?

P2860

Q21089784-F961F0EE-7B77-4884-AA91-E95B765E00BB Q21129149-538A57BA-9D21-41AD-952A-1331FE1ED115 Q21129387-D03B23FE-3FA2-4A64-A703-BE44F47DBFC6 Q21972817-5ADF3F75-BBDA-4F47-A8E2-01190D52F8D8 Q24595389-B3958264-7EDC-48E8-9EAA-A0519B5EF037 Q24616738-F8FDD899-9249-4388-8C86-04A9CC9C907A Q24634013-B0D35730-C204-4F82-9CE5-E76FCF371FD1 Q26746133-C267D2DC-B6B8-4768-A91D-A8CB4FD78A87 Q26746137-C0DC9BB7-1D02-4C78-B96A-BBE93D6948FB Q26765995-C32EFB55-A7B9-4D0C-94A3-8EF6915AA3CF Q27027381-6F4B53E5-71CE-4E44-9CFF-3BA1E9ABAE2D Q30359998-5428D2E6-EB03-4514-81E7-0D6F1537CAA5 Q30377709-191742C1-53CE-4E90-9294-3B17BC3CA81D Q30401421-6227153F-D02E-450F-889C-21A174517249 Q30402789-14361B8F-299C-4808-9054-726539F50C8E Q30444312-347E358F-4F7F-4F70-993A-748A76711FAA Q30531761-445B968C-BE17-44E4-BD27-5D35288A0C8D Q30833479-E27DAD5C-7066-4668-861B-B5ECF93758AF Q30843010-7BF1733C-1A6C-4EC5-8B43-3BFC6326EF28 Q30847957-9D8F18D0-1A69-4AA4-989D-45B15CD215AD Q33635662-97EA175F-D654-4BA6-AA95-C89C6D0AEA64 Q33937677-334B9570-C37A-4B4C-9824-6DBBF315E268 Q34325119-0CA0380D-A0A7-4802-B8FE-D38FE333AF44 Q34343456-BEC045BE-39D9-43B4-AC4D-AAA6F70BF204 Q34396223-BA06C6CC-3E6B-4171-A0A2-29FF0032B7C0 Q34438146-729AD48C-C267-457F-BE96-EA8AB98E56F6 Q34524116-A5B7A756-1C11-4DAB-A439-AB0F24834A98 Q34535259-6C8BFDAA-951C-4EA3-8D7B-DE847852F0A8 Q34546304-CEF66A18-3996-41A5-807F-978F7CC590D4 Q35126018-0C5ADB44-7460-468C-BE45-1B877F4040D0 Q35936959-5A48C31F-1F47-45B1-95DB-84D8A0E35BAF Q36839080-8EA227F4-9B4A-40E6-B00E-4FCD41566516 Q36999815-5B1D39F1-1A92-45FB-BA2C-BD31A8A64A3B Q37262799-85035BD8-EAA4-472A-A381-E0BECDABC8FB Q37722650-91E3C215-3062-4EA2-B2A2-8EAAF9CB0B2A Q38023813-AF13633A-0978-41C5-80E6-3068B7FCA165 Q38061522-51C74B14-DCE1-47CD-8253-B295F3397A7E Q38103475-84EB5E92-9052-4AAA-A5AD-759823FD1CE7 Q38186809-ED0A6F83-2F93-4032-A634-CD42207878A9 Q38351502-B254D709-38FE-4E9A-B9AC-94434A72311A

P2860

Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects

http://www.wikidata.org/entity/Q24613764

description

2011 nî lūn-bûn

@nan

2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Psilocybin occasioned mystical ...... ersisting dose-related effects

@ast

Psilocybin occasioned mystical ...... ersisting dose-related effects

@en

Psilocybin occasioned mystical ...... ersisting dose-related effects

@nl

type

label

Psilocybin occasioned mystical ...... ersisting dose-related effects

@ast

Psilocybin occasioned mystical ...... ersisting dose-related effects

@en

Psilocybin occasioned mystical ...... ersisting dose-related effects

@nl

prefLabel

Psilocybin occasioned mystical ...... ersisting dose-related effects

@ast

Psilocybin occasioned mystical ...... ersisting dose-related effects

@en

Psilocybin occasioned mystical ...... ersisting dose-related effects

@nl

P1433

Q24613764-91CFB507-A3C3-4897-AAAD-D9B3C1D6955B

P1476

Q24613764-A607D99C-4727-405E-B9B2-8389168D4529

P2093

Q24613764-1D3A1259-2FAA-4694-BDB6-B3402A8521FB

Q24613764-488E51C2-D742-405B-A706-8B63AFAC2B8F

Q24613764-701A185B-59B8-4034-8DDF-BF235B727260

Q24613764-96F0A464-95A0-48C5-AA9E-E2056D4C36FA

Q24613764-98A34CC1-67D8-4497-B9C8-4E107189AD04

Q24613764-F2412E4E-37F8-4006-A185-849D01A47588

P2860

Q24613764-02C69722-ED74-4C9B-B5B9-DD29A9A8F354

Q24613764-3AC181FC-1D16-4F3A-8216-94F6866FA7F4

Q24613764-5E108C25-0A09-427B-BC0D-F8157D148244

Q24613764-6B30E669-03DA-4E2E-A18D-5786F6954523

Q24613764-70E01713-E020-41DE-B70A-06D8CFDD5E1C

Q24613764-73D2E3BF-C79C-4259-9091-4ECF0641E6D4

Q24613764-756B46CF-6F13-444C-B979-F385086995D7

Q24613764-85C08328-4E98-43B7-BDA9-E990024B649F

Q24613764-85C10470-D644-49CB-B9FA-ED721BC15E84

Q24613764-8B134A2B-B5B4-4A9D-99E9-D9211CB5D17D

P2888

Q24613764-D1BB0A67-5F48-4E79-8FB7-77D41FACC918

P304

Q24613764-83C42686-89C6-4519-9415-FB1B2A027720

P31

Q24613764-902FF268-BF8A-43CA-9AAA-ECAF297EB9EE

P3181

Q24613764-A5A9E172-0DAA-4D8F-B0E6-81D7156341BB

P356

Q24613764-7E131E0C-67B4-45FE-9D93-6FC24C5E5A1D

P407

Q24613764-F9F5A423-F253-43B8-B0BF-25A821AABF82

P433

Q24613764-5102D1F5-EF8A-4810-95AF-93B8F50078D2

P478

Q24613764-BAA7BB7F-9EF6-4793-9B46-E0FA039DA319

P577

Q24613764-8AB685B7-1715-4477-A655-94D08E0E2CAB

P5875

Q24613764-7E44B7A2-D8A4-4C7C-8D6F-9CC1B1831DAE

P6179

Q24613764-934F65EF-7AD4-4940-A29C-03CECDC987B9

P698

Q24613764-FF034E3B-DCF4-4203-A535-0C416E3C2720

P932

Q24613764-5163647A-AFFE-4344-A10C-28690C775B1C

P3181

P356

S00213-011-2358-5

P1433

Psychopharmacology

P1476

Psilocybin occasioned mystical ...... ersisting dose-related effects

@en

P2093

Brian D Richards

http://www.w3.org/2001/XMLSchema#string

Matthew W Johnson

http://www.w3.org/2001/XMLSchema#string

Robert Jesse

http://www.w3.org/2001/XMLSchema#string

Roland R Griffiths

http://www.w3.org/2001/XMLSchema#string

Una McCann

http://www.w3.org/2001/XMLSchema#string

William A Richards

http://www.w3.org/2001/XMLSchema#string

P2860

Attenuation of anticipation: A therapeutic use of lysergic acid diethylamide

Human hallucinogen research: guidelines for safety

Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later

Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance

Do hallucinogens cause residual neuropsychological toxicity?

Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer.

REACTIONS TO PSILOCYBIN ADMINISTERED IN A SUPPORTIVE ENVIRONMENT.

Some observations on psilocybin, a new hallucinogen, in volunteer subjects.

Experimental psychiatry. V. Psilocybine, a new psychotogenic drug.

P2888

s00213-011-2358-5

P304

649-65

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

812202

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S00213-011-2358-5

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

218

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51220128

http://www.w3.org/2001/XMLSchema#string

P6179

1001926767

http://www.w3.org/2001/XMLSchema#string

P698

21674151

http://www.w3.org/2001/XMLSchema#string

P932

3308357

http://www.w3.org/2001/XMLSchema#string